當(dāng)前位置：   首頁 > 需求大廳

 >  特色服務(wù) 

 >  信息服務(wù) 

1.Bulletin of the Chemical Society of Japan, Volume 26, Pages 119-122, Journal, 1953 2.Dalton Transactions 2017,vol. 46, # 5, p. 1510 - 1519 3.Design and evaluation of ophthalmic pharmaceutical products. In Banker GS, Rhodes CT, eds. Modern Pharmaceutics, 4th edn. New York Marcel Dekker, 2002 415-478 4.Ixabepilone plus capecitabine with capecitabine alone for metastatic breast cancer 5.Journal of Photochemistry and Photobiology, B Biology, Volume 97, Issue 1, Pages 18-21, Journal, 2009 6.Journal of Photochemistry and Photobiology, B Biology, Volume 115, Pages 51-57, Journal; Online Computer File, 2012 7.Nair AD, Lach JL. The kinetics of degradation of chlorobutanol. J Am Pharm Assoc (Sci) 1959; 48 390-395. 8.Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine 9.Plasma?renin?activity-guided strategy for the management of hypertension. 10.Stability of chlorobutanol in aqueous solutions Journal of the American Pharmaceutical Association (1961), Volume 6, Issue 7, July 1966, Pages 372-373 11.Talanta, Volume 146, Pages 732-736, Journal; Online Computer File, 2016   [更多]

1. Miller J. Ogidigben, Teh-Ching Chu and David E. Potter. Naphazoline-induced neuroendocrine changes Increases in ANP and cGMP levels 2. Robert J. Dockhorn and Thomas G. Duckett. Comparison of Naphcon-A and Its components 3. Mark B, Abelson MD, Salim I, et al. Tolerance and absence of rebound vasodilation following topical ocular decongestant usage 4. Ogidigben MJ, Chu TC, Potter DE. Naphazoline-induced suppression of aqueous humor pressure and flowinvolvement of central and peripheral alpha(2) I(1) receptors 5. The efficacy of long-term treatment with Tolvaptan to prolong the time until dialysis initiation in patients with chronic kidney disease and heart failure 6. Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion 7. Tolvaptan Efficiently Reduces Intracellular Fluid Working Toward a Potential Treatment Option for Cellular Edema 8. Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascites 9. Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease 10. Safety and Effectiveness of Tolvaptan Administration after Total Arch Replacement 11. Nephrol Dial Transplant. 2018 Oct 12. doi 10.1093ndtgfy297. [Epub ahead of print] 12. Nephrol Dial Transplant. 2018 Oct 11. doi 10.1093ndtgfy298. [Epub ahead of print] 13. Development and validation of RP-HPLC method for simultaneous estimation of Ofloxacin and Ornidazole inpresence of Ornidazole Impurity in combined pharmaceutical dosage form 14. Stability-indicating methods for the determination of Ornidazole in the presence of its degradate according to ICH guidelines 15. A sensitive HPLC method of determination of 2-methyl 5-nitro imidazole & reaction mass of intermediates of ornidazole in ornidazole bulk manufacturing 16. Development and validation of a reversed-phase HPLC method for the analysis of ornidazole in pharmaceutical dosage forms 17. On the hydrolytic behavior of tinidazole, metronidazole,   [更多]

文獻(xiàn)標(biāo)題及相關(guān)內(nèi)容： 1.Ohmukai O.Lipo- NSAID preparation[J].Adv Drug Deliv Rev 2.Less pain on injection by a new formulation of propofol? A comparison with propofol LCT 3.Tohno, M.，Konishi , Y.，Kojima , H., Kawahara, K. and Horiba, M. (1992 ) Pharmacokinetics and metabolic studies of LFP83 in man after the single and repeated intravenous administration. Clin. Rep. 26, 3907-3921. 4.Naito, Y. et al.：Arzneim.-Forsch.Drug Res., 46(II), 698-700, 1996 5.What is the Role of NSAIDs in Pre-emptive Analgesia?   [更多]

文獻(xiàn)標(biāo)題及相關(guān)內(nèi)容： 1. In vitro and in vivo metabolism of rimonabant (SR-141716), a cannabinoid (CB1) receptor antagonist 2. 各種動物およびヒトにおける LFP83 の體內(nèi)動態(tài) 3. LFP83靜脈內(nèi)投與によるラット分布, 代謝および排泄 4. 34 - Disorders of Blood Cell Production in Clinical Oncology 5. Predictive evaluation of pharmaceutical properties of direct compression tablets containing theophylline anhydrate during storage at high humidity by near-infrared spectroscopy   [更多]

具體形式為填寫調(diào)查問卷 要求： 1.醫(yī)藥行業(yè)從業(yè)人員 2.醫(yī)學(xué)院學(xué)生 3.醫(yī)生 通過在線調(diào)研后會被我們藥智匯備案為科研調(diào)研人員，任何調(diào)研項目優(yōu)先通知。 投稿后添加QQ群：905763758，問卷鏈接以及注意事項都在群里   [更多]

文獻(xiàn)標(biāo)題以及其它信息 1：ass Dermatol Sifilogr. 1961 Nov-Dec;14:283-94. [The intravenous use of lysozyme in the pain caused by cancer and first observations concerning the pharmacological combinations].[Article in Italian]SCOLARI EG, NANNELLI M, VALLECCHI C. PMID: 13909883 2：Minerva Medicoleg. 1963 Sep-Oct;83:130-4. [2 FATAL CASES CAUSED BY THE 1ST INTRAMUSCULAR INJECTION OF LYSOZYME]. [Article in Italian]LUVONI R. PMID: 14116728 3：Minerva Med. 1963 Apr 11;54:1016-21. [Lysozyme used by the intraarticular route in chronic arthrosynovitis. Clinical observations]. [Article in Italian]BRUNELLI G, POGGI AE. PMID: 1401627 4：Blade-Font, Artur; Rocabayera, Teodoro de Mas - [Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1982, p. 841 - 848] 5：Yoshida; Sato; Moroi - [Arzneimittel-Forschung/Drug Research, 1993, vol. 43, # 5, p. 601 - 606] 備注：提供PDF電子檔原件   [更多]

求購磷酸西格列汀片信息   [更多]

高價求《云南省中藥飲片標(biāo)準(zhǔn)》葛根粉云信息，如果你有標(biāo)準(zhǔn)，請聯(lián)系我，價格可談   [更多]

1.廣東省中藥炮制規(guī)范1984年版 2.山東省中藥炮制規(guī)范 2002年版 3.江蘇省中藥飲片炮制規(guī)范2002版 4. 青海省藏藥炮制規(guī)范2010版 5.新建維吾爾自治區(qū)中藥加工炮制規(guī)范（2010版） 6.甘肅省中藥炮制規(guī)范（2009年版） 7.湖北省中藥飲片炮制規(guī)范 2009年版 8.北京市中藥飲片切制經(jīng)驗1960版 9.北京市中藥飲片切制規(guī)范 （上+下兩冊）1975版 10.北京市中藥炮制規(guī)范 1986年版 11.中藥切制規(guī)范（武漢中醫(yī)藥協(xié)會） 12.中藥飲片切制規(guī)范（天津衛(wèi)生局1975版） 13.云南省中藥咀片炮灸規(guī)范1974版 14.青海省中藥炮制規(guī)范（1991年版） 15.廣東省中藥材飲片加工炮制手冊1977版 16.中草藥炮制規(guī)范（武漢革委會1979版） 17.河北中藥材炮制規(guī)范 1979版 18.山西中藥炮制規(guī)范1984 19.《河北省中藥材標(biāo)準(zhǔn)》(試行)2017版 20.中藥飲片炮制規(guī)范（沈陽市衛(wèi)生局） 1962 21.上海市中藥飲片炮制規(guī)范1962、1973、1980 22.四川省中藥飲片炮制規(guī)范2002版   [更多]

求購達(dá)托霉素信息   [更多]